PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0023895|liver disease |
| Sentences | 86 |
| PubMedID- 22160684 | In a significant portion of patients chronic hepatitis c infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 22721429 | An infection of hepatitis c virus may lead to serious liver diseases including chronic hepatitis, cirrhosis and hepatocellular carcinoma with poor prognosis . |
| PubMedID- 24575168 | Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail. |
| PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
| PubMedID- 20424599 | For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates. |
| PubMedID- 22098185 | Evaluation of the adverse effect of premature discontinuation of pegylated interferon alpha-2b and ribavirin treatment for chronic hepatitis c virus infection: results from kyushu university liver disease study. |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 23213601 | 46-year-old female patient whose blood group was “a1 positive” underwent deceased donor liver transplantation (ddlt) from identical blood group donor for end-stage liver disease due to hepatitis c with meld score of 26. pre-operatively, she had comorbidities in the form of diabetes mellitus and recurrent hepatic hydrothorax requiring frequent therapeutic aspiration. |
| PubMedID- 21145859 | Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis c patients with minimal liver disease. |
| PubMedID- 21188525 | Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis c infection. |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
| PubMedID- 22172892 | A 43-year-old man with end-stage liver disease due to hepatitis c and b virus infections and alcoholic cirrhosis received a liver transplantation under immunosuppressive treatment with tacrolimus and mycophenolate mofetil. |
| PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
| PubMedID- 22359532 | Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease. |
| PubMedID- 22970270 | Eligible patients were ≥18 years of age, had compensated liver disease due to chronic hepatitis c virus (hcv) infection (any fibrosis stage, including compensated cirrhosis), detectable plasma hcv rna levels, and had received no previous treatment for hepatitis c. patients were excluded if they were co-infected with human immunodeficiency virus or hepatitis b virus or had any other cause of liver disease, severe depression or psychiatric disorder, or active substance or alcohol consumption >20 g/day in the last five years, as evaluated by a questionnaire. |
| PubMedID- 22087124 | Background: nonalcoholic fatty liver disease develops in patients with chronic hepatitis c. |
| PubMedID- 22619486 | Reported on 3 patients suffering from sp after liver transplantation, namely, two 42- and 62-year-old males with end-stage liver disease due to hepatitis c infection without significant other past medical or surgical history and a 59-year-old alcoholic. |
| PubMedID- 25616017 | Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis c. |
| PubMedID- 22163170 | The most common indication for lt was end-stage liver disease attributed to hepatitis c infection. |
| PubMedID- 20616580 | Lipid metabolism and liver disease in hepatitis c viral infection. |
| PubMedID- 20388084 | Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol. |
| PubMedID- 22318146 | hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma. |
| PubMedID- 24130726 | This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. |
| PubMedID- 25716364 | Functional and morphological myocardial changes in hepatitis c virus patients with end-stage liver disease. |
| PubMedID- 23241078 | The economic burden of advanced liver disease among patients with hepatitis c virus: a large state medicaid perspective. |
| PubMedID- 22505377 | Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer. |
| PubMedID- 20367803 | liver disease due to hepatitis c virus (hcv) infection is a leading cause of non-aids-related morbidity and mortality in patients infected with hiv. |
| PubMedID- 23796722 | Methods: two patients, who had already received a liver transplant (lt) in the past, with an end-stage liver disease due to recurrent hepatitis c virus cirrhosis, suffering acute-on-chronic liver failure while on the waiting list for an lt, received ht as a bridge to whole-organ retransplantation. |
| PubMedID- 26444967 | Are anti-tnf-alpha agents safe for treating psoriasis in hepatitis c virus patients with advanced liver disease. |
| PubMedID- 21029257 | Uptake of hepatitis c antibody testing in patients with end-stage liver disease in glasgow, 1993-2007. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 23497336 | Eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, increases platelet counts in adult patients with chronic immune thrombocytopenia (itp) and chronic liver disease due to hepatitis c virus infection . |
| PubMedID- 25961570 | Reduced expression of ifnar1 has also been observed in the liver biopsies of chronic liver disease patients with hepatitis c virus infection . |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 20678018 | End-stage liver disease due to hepatitis c virus infection (hcv) is the principal indication for liver transplantation. |
| PubMedID- 22797645 | Objective: to determine the effect of silymarin on liver disease activity in patients with chronic hepatitis c virus (hcv) infection unsuccessfully treated with interferon-based therapy. |
| PubMedID- 23703797 | Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv). |
| PubMedID- 23633957 | These observations support a model of hepatic inflammation induced by phagocytic uptake of hcv by resident macrophages/kupffer cells to trigger il-1β and drive expression of proinflammatory cytokines, with il-1β expression associating with liver disease in patients with chronic hepatitis c infection (figure. |
| PubMedID- 21743223 | She was suffering from end-stage liver disease due to hepatitis c virus (hcv) infection and renal disease due to diabetic nephropathy. |
| PubMedID- 23226395 | liver disease due to hepatitis c virus (hcv) infection is an important health problem worldwide. |
| PubMedID- 22457795 | It is known that most cases of hcc developed from a pre-existing chronic liver disease, usually due to hepatitis c virus, hepatitis b virus or alcohol. |
| PubMedID- 24815847 | Chronic liver disease due to hepatitis c affects a large number of hiv-infected patients in latin america and currently poses important challenges for the health systems in the region. |
| PubMedID- 21258658 | Hepatitis b and hepatitis c are important causes of chronic liver disease globally. |
| PubMedID- 21031537 | Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis c. |
| PubMedID- 20617177 | Chronic hepatitis c is associated with severe liver disease including hepatitis, liver cirrhosis and hepatocellular carcinoma and it is the most frequent indication for liver transplantation 4. |
| PubMedID- 21209701 | End-stage liver disease due to hepatitis c (hcv) and cirrhosis from alcohol (ald) are the commonest indications for liver transplantation in the western countries. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 21957404 | Fifteen patients suffered from end-stage liver disease due to hepatitis c; 7, due to hepatitis c with hepatocellular carcinoma; and the remaining 3, due to hepatocellular carcinoma with negative viral markers. |
| PubMedID- 23874824 | Among the main causes of liver disease, co-infection with the hepatitis c (hcv) or hepatitis b (hbv) virus is the most frequent and has the worst prognosis 3. |
Page: 1 2